Ras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications
WO2020247345A1
Non-hygroscopic crystalline salts of a pyrazole compound, and pharmaceutical compositions and use thereof
WO2020242960A1
Compounds targeting proteins and pharmaceutical compositions thereof, and their therapeutic applications
US2020148663A1
Substituted isoindolinones
AU2019309894A1
Bifunctional compounds as CDK modulators
AU2019284608A1
Aminoamide compounds
AU2019284605A1
Fused thiophene compounds
WO2019191451A1
Thienopyrimidinone compounds
WO2019173224A1
Deuterated compounds and chimeras and uses thereof
US2019062320A1
Ether compounds and uses thereof
US2018354967A1
Bicyclic compounds and methods of use
WO2018169777A1
Compounds targeting proteins, compositions, methods, and uses thereof
CA3043938A1
Thienopyrrole derivatives for use in targeting proteins, compositions, methods, and uses thereof
WO2017201069A1
Oxoindoline derivatives as protein function modulators
TW201805271A
Pyridinethiones, pharmaceutical compositions thereof, and their therapeutic use for treating a proliferative, inflammatory, neurodegenerative, or immune-mediated disease
US2017100369A1
Pharmaceutical compositions comprising one or more pyrone compounds, and their use for treating inflammatory and neurodegenerative diseases
US2017101379A1
Pyridone compounds, pharmaceutical compositions thereof, and their therapeutic use for treating proliferative diseases
MX2017014567A
Compounds targeting proteins, compositions, methods, and uses thereof.
WO2015195474A1
Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating inflammatory, neurodegenerative, or immune-mediated diseases
